1-(4-fluorophenyl)-1H-indole-3-carboxaldehyde

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 1-(4-fluorophenyl)-1H-indole-3-carboxaldehyde
• 英文别名: 1-(4-Fluorophenyl)indole-3-carbaldehyde
• 化学式: C₁₅H₁₀FNO
• mdl: MFCD03074142
• 分子量: 239.249
• InChiKey: RVYKBUHPOPVEPZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  22
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(4-fluorophenyl)-1H-indole-3-carboxaldehyde 在 lithium perchlorate 、 三乙酰氧基硼氢化钠 、 溶剂黄146 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 生成 (2R,3R)-2-(2,4-difluorophenyl)-3-[4-[[1-(4-fluorophenyl)indol-3-yl]methyl]piperazin-1-yl]-1-(1,2,4-triazol-1-yl)butan-2-ol
  参考文献：
  名称：

  新型 1-卤代苄基吲哚连接的三唑衍生物作为抗真菌剂的合成和活性

  摘要：

  DOI：

  10.5012/bkcs.2011.32.1.307
• 作为产物：
  描述：

  吲哚 在 sodium hydride 、 三氯氧磷 作用下， 以 二甲基亚砜 为溶剂， 生成 1-(4-fluorophenyl)-1H-indole-3-carboxaldehyde
  参考文献：
  名称：

  新型 1-卤代苄基吲哚连接的三唑衍生物作为抗真菌剂的合成和活性

  摘要：

  DOI：

  10.5012/bkcs.2011.32.1.307

文献信息

• Copper-catalyzed N-arylation of azoles and diazoles using highly functionalized trivalent organobismuth reagents
  作者：Pauline Petiot、Julien Dansereau、Alexandre Gagnon

  DOI：10.1039/c4ra02467b

  日期：——

  The N-arylation of indoles, indazoles, pyrroles, and pyrazoles using highly functionalized trivalent arylbismuth reagents is reported. The reaction is promoted by a substoichiometric amount of copper acetate, and it tolerates a wide diversity of functional groups on the azole and the organobismuth reagent. The method is also applied to the N-arylation of tryptophan derivatives.

  报道了使用高度官能化的三价芳基铋试剂使吲哚，吲唑，吡咯和吡唑的N-芳基化。亚化学计量的乙酸铜促进了该反应，并且该反应可耐受唑和有机铋试剂上的多种官能团。该方法也适用于色氨酸衍生物的N-芳基化。
• .sigma. Ligands with Subnanomolar Affinity and Preference for the .sigma.2 Binding Site. 1. 3-(.omega.-Aminoalkyl)-1H-indoles
  作者：Jens Perregaard、Ejner K. Moltzen、Eddi Meier、Connie Sanchez

  DOI：10.1021/jm00011a019

  日期：1995.5

  2-methoxy substituents. High affinity for both sigma 1 and sigma 2 binding sites was achieved with these compounds. Additionally, these compounds had relatively high affinity for serotonin 5-HT1A and 5-HT2A, dopamine D2, and adrenergic alpha 1 receptors. Introduction of a 4-fluorophenyl substituent at the indole nitrogen atom rendered very selective sigma 2 ligands with subnanomolar affinity for the sigma 2

  合成了一系列的4-（1H-吲哚-3-基）-1-丁基取代的4-苯基哌啶，4-苯基-1,2,3,6-四氢吡啶和4-苯基哌嗪。苯基任选地被4-氟或2-甲氧基取代基取代。用这些化合物实现了对sigma 1和sigma 2结合位点的高亲和力。另外，这些化合物对5-羟色胺5-HT1A和5-HT2A，多巴胺D2和肾上腺素α1受体具有较高的亲和力。在吲哚氮原子处引入4-氟苯基取代基使得对σ2结合位点具有亚纳摩尔亲和力的非常选择性的σ2配体。这种化合物的原型是1-（4-氟苯基）-3- [4- [4-（4-氟苯基）-1-哌啶基] -1-丁基] -1H-吲哚，11a（代码Lu 29） -253）。该化合物具有以下结合亲和力：IC50（sigma 1）= 16 nM，IC50（sigma 2）= 0.27 nM，IC50（5-HT1A）= 22,000 nM，IC50（5-HT2A）= 270 nM，IC50（D2）=
• Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication
  作者：Angela Corona、Valentina Noemi Madia、Riccardo De Santis、Candida Manelfi、Roberta Emmolo、Davide Ialongo、Elisa Patacchini、Antonella Messore、Donatella Amatore、Giovanni Faggioni、Marco Artico、Daniela Iaconis、Carmine Talarico、Roberto Di Santo、Florigio Lista、Roberta Costi、Enzo Tramontano

  DOI：10.1016/j.antiviral.2023.105697

  日期：2023.9

  an ideal target for drug discovery. SARS-CoV-2 helicase, the non-structural protein 13 (nsp13) is a highly conserved protein among all known coronaviruses, and, at the moment, is one of the most explored viral targets to identify new possible antiviral agents. In the present study, we present six diketo acids (DKAs) as nsp13 inhibitors able to block both SARS-CoV-2 nsp13 enzymatic functions. Among them

  对于 RNA 病毒，RNA 解旋酶长期以来被认为在病毒复制周期中发挥着关键作用，促进病毒 RNA 的正确折叠和复制，因此代表了药物发现的理想靶标。SARS-CoV-2 解旋酶，即非结构蛋白 13 (nsp13) 是所有已知冠状病毒中高度保守的蛋白质，目前是识别新的可能抗病毒药物的研究最多的病毒靶标之一。在本研究中，我们提出了六种二酮酸 (DKA) 作为 nsp13 抑制剂，能够阻断 SARS-CoV-2 nsp13 酶功能。其中四种化合物能够在低微摩尔范围内抑制病毒复制，并且对其他人类冠状病毒（例如 HCoV229E 和 MERS CoV）也具有活性。结合模式的实验研究揭示了 ATP 非竞争性抑制动力学，不受底物置换效应的影响，表明变构结合模式得到了分子模型计算的进一步支持，预测了与位于 RecA2 的变构保守位点的结合领域。
• Potential applications for sigma receptor ligands in cancer diagnosis and therapy
  作者：Aren van Waarde、Anna A. Rybczynska、Nisha K. Ramakrishnan、Kiichi Ishiwata、Philip H. Elsinga、Rudi A.J.O. Dierckx

  DOI：10.1016/j.bbamem.2014.08.022

  日期：2015.10

  Sigma receptors (sigma-1 and sigma-2) represent two independent classes of proteins. Their endogenous ligands may include the hallucinogen N,N-dimethyltryptamine (DMT) and sphingolipid-derived amines which interact with sigma-1 receptors, besides steroid hormones (e.g., progesterone) which bind to both sigma receptor sub-populations. The sigma-1 receptor is a ligand-regulated molecular chaperone with various ion channels and G-protein-coupled membrane receptors as clients. The sigma-2 receptor was identified as the progesterone receptor membrane component 1 (PGRMC1). Although sigma receptors are over-expressed in tumors and up-regulated in rapidly dividing normal tissue, their ligands induce significant cell death only in tumor tissue. Sigma ligands may therefore be used to selectively eradicate tumors. Multiple mechanisms appear to underlie cell killing after administration of sigma ligands, and the signaling pathways are dependent both on the type of ligand and the type of tumor cell. Recent evidence suggests that the sigma-2 receptor is a potential tumor and serum biomarker for humaniung cancer and an important target for inhibiting tumor invasion and cancer progression. Current radiochemical efforts are focused on the development of subtype-selective radioligands for positron emission tomography (PET) imaging. Right now, the mostpromising tracers are [F-18]fluspidine and [F-18]FTC-146 for sigma-1 receptors and [C-11]RHM-1 and [F-18]ISO-1 for the sigma-2 subtype. Nanoparticles coupled to sigma ligands have shown considerable potential for targeted delivery of antitumor drugs in animal models of cancer, but clinical studies exploring this strategy in cancer patients have not yet been reported. This article is part of a Special Issue entitled: Membrane channels and transporters in cancers. (C) 2014 Elsevier B.V. All rights reserved.
• From mixed sigma-2 receptor/P-glycoprotein targeting agents to selective P-glycoprotein modulators: Small structural changes address the mechanism of interaction at the efflux pump
  作者：Carmen Abate、Maria Laura Pati、Marialessandra Contino、Nicola Antonio Colabufo、Roberto Perrone、Mauro Niso、Francesco Berardi

  DOI：10.1016/j.ejmech.2014.10.082

  日期：2015.1

  Generations of modulators of the efflux pump P-glycoprotein (P-gp) have been produced as tools to counteract the Multidrug Resistance (MDR) phenomenon in tumor therapy, but clinical trials were not successful so far. With the aim of contributing to the development of novel P-gp modulators, we started from recently studied high-affinity sigma-2 (sigma(2)) receptor ligands that showed also potent interaction with P-gp. For sigma(2) receptors high-affinity binding, a basic N-atom is a strict requirement. Therefore, we reduced the basic character of the N-atom present in these ligands, and we obtained potent P-gp modulators with poor or null sigma(2) receptor affinity. We also evaluated whether modulation of P-gp by these novel compounds involved consumption of ATP (as P-gp substrates do), as a source of energy to support the efflux. Surprisingly, even small structural changes resulted in opposite behavior, with amide 13 depleting ATP, in contrast to its isomer 18. Two compounds, 15 and 25, emerged for their potent activity at P-gp, and deserve further investigations as tools for P-gp modulation. (C) 2014 Elsevier Masson SAS. All rights reserved.